Journal Article Summary
This article investigates the compliance of pregnant women in Hawassa city, South Ethiopia, with iron folic acid (IFA) supplementation, which is crucial for preventing iron deficiency anemia during pregnancy. Anemia is a significant public health issue that can lead to adverse maternal and fetal outcomes, making adherence to IFA recommendations vital. The World Health Organization advocates for universal IFA supplementation to mitigate these risks, emphasizing the need for understanding compliance levels and the factors influencing them.
The study involved a community-based cross-sectional analysis of 422 pregnant women in their third trimester, using face-to-face interviews and pill counts to assess compliance. The results indicated that only 38.3% of participants adhered to the recommended IFA intake. Key factors affecting compliance included awareness of the importance of IFA, previous pregnancy complications, and side effects experienced during prior IFA use. Women who understood the benefits of IFA were significantly more likely to comply, while those who had complications or side effects were less likely to do so.
Limitations of the study include the reliance on pill counts rather than more precise methods like electronic monitoring or biochemical assessments of compliance. This could affect the accuracy of the findings. Patients should discuss their IFA supplementation with healthcare providers, especially if they have experienced side effects or complications in previous pregnancies. Understanding the importance of IFA and addressing any concerns can help improve adherence and ultimately enhance maternal and fetal health outcomes.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Kassa Zemenu Yohannes, Awraris Tegibelu, Daba Alemneh Kabeta, Tenaw Zelalem. Compliance with iron folic acid and associated factors among pregnant women through pill count in Hawassa city, South Ethiopia: a community based cross-sectional study. Reproductive Health 2019. DOI: 10.1186/s12978-019-0679-8. PMID: 30736812. PMCID: PMC6367743.
Featured Pill Pals Product
Folic Acid 1 mg Tablets --- Generic For Folvite --- Modavar
Folic Acid 1 mg Tablets — Generic For Folvite — Modavar is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
